Acyclovir Should NOT Be Given as IV Push
No, acyclovir must never be administered as an intravenous push—it must be infused slowly over at least 1 hour to prevent potentially fatal renal tubular damage. 1
Critical Administration Requirements
The FDA explicitly warns that acyclovir for injection is intended for intravenous infusion only and must be given over a period of at least 1 hour to reduce the risk of renal tubular damage. 1 The drug should not be administered as a bolus injection. 1
Why IV Push Is Dangerous
- Crystalluria and acute kidney injury: Rapid bolus injection causes acyclovir crystal formation in renal tubules and collecting ducts, leading to obstructive nephropathy. 2
- High nephrotoxicity rates: Up to 20% of patients develop reversible nephropathy, typically manifesting after 4 days of IV therapy, but this risk is dramatically increased with bolus administration. 3
- Fatal outcomes reported: Renal failure resulting in death has been documented with acyclovir therapy, particularly when proper infusion protocols are not followed. 1
Proper IV Administration Protocol
Infusion rate: Administer over at least 1 hour (never faster). 1, 4
Hydration requirements:
- Maintain adequate hydration before, during, and after administration to prevent crystal precipitation. 5, 3
- Ensure patients receive at least 1.5 liters of water daily during therapy. 6
- The risk of nephropathy is considerably reduced by slow infusion with adequate hydration. 2
Monitoring:
- Check renal function at baseline, 2-3 times weekly during induction, and every 1-2 weeks during maintenance. 6
- Monitor especially closely within the first 48 hours of treatment when AKI risk is highest. 7
Common Pitfall to Avoid
The most dangerous error is attempting rapid administration to save time or due to misunderstanding of the drug's properties. While some beta-lactam antibiotics can be given as IV push, acyclovir absolutely cannot. 4 The crystallization occurs rapidly with bolus injection, and the resulting tubular obstruction can be irreversible if severe. 2
High-Risk Situations Requiring Extra Caution
- Dehydrated patients: Significantly increased risk of crystal-induced nephropathy. 7
- Pre-existing renal impairment: Requires dose reduction and even slower infusion. 3, 1
- Concomitant nephrotoxic drugs: Vancomycin and NSAIDs dramatically increase AKI risk (OR 4.3 and 2.6 respectively). 8
- Diabetes: Independent risk factor for acyclovir-associated AKI (OR 3.6). 8